BlackRock Health Sciences Trust is a Buy for income investors, offering an 8% yield, NAV discount, and resilient healthcare ...

Inflation, interest rates, and broader economic uncertainty have forced companies across many sectors to prioritize ...

Playing in just its second home contest of the season, the Bowling Green Christian Academy’s varsity boys basketball team ...

Shares of biotechnology firm MacroGenics are under significant pressure following reports that confirmatory clinical trials ...

Penn leaders say the fund is designed to address a "key funding gap in the innovation ecosystem.” ...

Here’s a closer look at the top pharmaceutical companies that have earned favorable rankings from Wolfe Research analysts. Johnson & Johnson takes the top spot with growth primarily driven by new ...

US biopharma Arcus Biosciences has announced the discontinuation of the Phase III STAR-221 study, being conducted in ...

Fred Alger Management, LLC ("Alger"), a privately held growth equity investment manager, today announced the quarterly rebalancing of the Alger Russell Innovation Index ("Index"). Following the close ...

Shares of Arcus Biosciences, Inc. RCUS, a clinical-stage biopharmaceutical company, declined 14.4% following the announcement ...

A catalyst for technology-based economic development in life sciences . In 1984, three of North Carolina’s largest ...